Novozymes: Acquisition of enzyme activities from Biocon completed
Novozymes A/S has completed the acquisition of the enzyme activities of Biocon Limited, Bangalore, India. In reference to stock exchange announcement no.17 of July 18, 2007, the acquisition was subject to shareholders' approval and approval by the relevant Indian regulatory bodies, which have now been granted.
The activities will be integrated into Novozymes' existing Indian and global activities and included in Novozymes' consolidated financial statements with effect from October 1, 2007.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.